COVID-19 Vaccine Boosters Targeting Omicron BA.4/BA.5 To Launch As Clinical Trials Continue

 
• By Brenda Sandburg

Pfizer/BioNtech’s and Moderna’s updated bivalent Omicron booster doses will be available in coming days. Pfizer/BioNtech has an ongoing study in individuals 12 and older and are preparing EUA application for those 6 months and older. Moderna completed enrollment of 512 participants in a Phase 2/3 trial.

COVID-19 vaccine booster
US FDA authorizes COVID-19 vaccine boosters targeting Omicron variants • Source: Shutterstock

More from Vaccines

More from Pink Sheet